Expression of Beta-catenin, COX-2 and iNOS in Colorectal Cancer: Relevance of COX-2 and iNOS Inhibitors for Treatment in Malaysia

Asian Journal of Surgery

Volumn 27, Issue 1, 2004, Pages 10-17

  Hong, Seok Kwan ^a   Gul, Yunus A ^a   Ithnin, Hairuszah ^a   Talib, Arni ^b   Seow, Heng Fong ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b HOSPITAL KUALA LUMPUR   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE INHIBITOR; NITRIC OXIDE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER SURGERY; CELL NUCLEUS; COLORECTAL CANCER; CYTOPLASM; ENZYME SYNTHESIS; FEMALE; HUMAN; HUMAN TISSUE; MALAYSIA; MALE; PROTEIN EXPRESSION; RETROSPECTIVE STUDY;

EID: 0346334837     PISSN: 10159584     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1015-9584(09)60237-2     Document Type: Article

References (40)

1. Ministry of Health. Malaysia Health Annual Report. Kuala Lumpur: Malaysian Ministry of Health, 2000.
2. Laurent-Puig P, Blons H, Cugene PH. Sequence of molecular genetic events in colorectal tumorigenesis. Eur J Cancer Prev 1999;8:S39-47.
3. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
4. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159-70.
5. Rubinfeld B, Albert I, Porfiri E, et al. Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science 1996;272:1023-6.
6. Goss KH, Groden J. Biology of the adenomatous polyposis coli tumour suppressor. J Clin Oncol 2000;18:1967-79.
7. Mann B, Gelos M, Siedow A, et al. Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci USA 1999;96:1603-8.
8. Smith WL, DeWitt DL. Prostaglandin endoperoxide H synthases-1 and -2. Adv Immunol 1996;62:167-215.
9. Ristimaki A, Honkanen N, Jankala H, et al. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 1997;57:1276-80.
10. Dannenberg AJ, Nasser KA, Boyle JO, et al. Inhibition of cyclooxygenase-2. An approach to preventing cancer of the upper aerodigestive tract. Ann NY Acad Sci 2001;952:109-15.
11. Smalley W, DuBois RN. Colorectal cancer and nonsteroidal antiinflammatory drugs. Adv Pharmacol 1997;39:1-20.
12. Poon R, Smits R, Li C, et al. Cyclooxygenase-two (COX-2) modulates proliferation in aggressive fibromatosis (desmoid tumour). Oncogene 2001;20:451-60.
13. Oshima M, Dinchuk JE, Kargman SL, et al. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996;87:803-9.
14. Taketo MM. Cyclooxygenase-2 inhibitors in tumorigenesis. J Natl Cancer Inst 1998;90:1609-20.
15. Rajnakova A, Goh PM, Chan ST, et al. Expression of differential nitric oxide synthase isoforms in human normal gastric mucosa and gastric cancer tissue. Carcinogenesis 1997;18:1841-5.
16. Ambs S, Merriam WG, Bennett WP, et al. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res 1998;58:334-41.
17. Lejeune P, Lagadec P, Onier N, et al. Nitric oxide involvement in tumour-induced immunosuppression. J Immunol 1994;149:2709-14.
18. Nguyen T, Brunson D, Crespi CL, et al. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Natl Acad Sci USA 1992;89:3030-4.
19. Vidal MJ, Zocchi MR, Poggi A, et al. Involvement of nitric oxide in tumor cell adhesion to cytokine-activated endothelial cells. J Cardiovasc Pharmacol 1992;20:S155-9.
20. Endo K, Terada T. Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumour grade, clinicopathologic parameters, p53 expression and patient survival. J Hepatol 2000;32:78-84.
21. Bienz M, Clevers H. Linking colorectal cancer to Wnt signaling. Cell 2000;103:311-20.
22. Iwamoto M, Ahnen DJ, Franklin WA, Maltzman TH. Expression of beta-catenin and full-length APC protein in normal and neoplastic colonic tissues. Carcinogenesis 2000;21:1935-40.
23. Willert K, Nusse R. Beta-catenin: a key mediator of Wnt signaling. Curr Opin Genet Dev 1998;8:95-102.
24. Chung DC. The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis. Gastroenterology 2000;119:854-65.
25. Wong NA, Pignatelli M. Beta-catenin - a linchpin in colorectal carcinogenesis? Am J Pathol 2002;160:389-401.
26. Mei JM, Hord NG, Winterstein DF, et al. Differential expression of prostaglandin endoperoxide H synthase-2 and formation of activated beta-catenin-LEF-1 transcription complex in mouse colonic epithelial cells contrasting in Apc. Carcinogenesis 1999;20:737-40.
27. Eberhart CE, Coffey RJ, Radhika A, et al. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994;107:1183-8.
28. Sano H, Kawahito Y, Wilder RL, et al. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 1995;55:3785-9.
29. Degen GH. Role of prostaglandin-H synthase in mediating genotoxic and carcinogenic effects of estrogens. Environ Health Perspect 1990;88:217-23.
30. Shao J, Sheng H, Aramandla R, et al. Coordinate regulation of cyclooxygenase-2 and TGF-beta1 in replication error-positive colon cancer and azoxymethane-induced rat colonic tumors. Carcinogenesis 1999;20:185-91.
31. Takahashi M, Mutoh M, Kawamori T, et al. Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis. Carcinogenesis 2000;21:1319-27.
32. Tomozawa S, Tsuno NH, Sunami E, et al. Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer. Br J Cancer 2000;83:324-8.
33. Pahl HL. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999;18:6853-66.
34. Haertel-Wiesmann M, Liang Y, Fantl WJ, Williams LT. Regulation of cyclooxygenase-2 and periostin by Wnt-3 in mouse mammary epithelial cells. J Biol Chem 2000;275:32046-51.
35. Denis M. Tumour necrosis factor and granulocyte macrophage colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanisms depend on the generation of reactive nitrogen intermediates. J Leukoc Biol 1991;49:380-7.
36. Scott-Burden T, Schini VB, Elizondo E, et al. Platelet-derived growth factor suppresses and fibroblast growth factor enhances cytokine-induced production of nitric oxide by cultured smooth muscle cells. Effects on cell proliferation. Circ Res 1992;71:1088-100.
37. Sherman PA, Laubach VE, Reep BR, Wood ER. Purification and cDNA sequence of an inducible nitric oxide synthase from a human tumor cell line. Biochemistry 1993;32:11600-5.
38. Stuehr DJ, Nathan CF. Nitric oxide - a macrophage product responsible for cytostasis and respiratory inhibition in tumour target cells. J Exp Med 1989;169:1543-55.
39. Brabletz T, Herrmann K, Jung A, et al. Expression of nuclear beta-catenin and c-myc is correlated with tumour size but not with proliferative activity of colorectal adenomas. Am J Pathol 2000;156:865-70.
40. Schlosshauer PW, Ellenson LH, Soslow RA. Beta-catenin and E-cadherin expression patterns in high grade endometrial carcinoma are associated with histological subtype. Mod Pathol 2002;15:1032-7.